Literature DB >> 11348718

Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various Archaeobacteria elicits rapid and prolonged specific protective immunity against infection with the facultative intracellular pathogen, Listeria monocytogenes.

J W Conlan1, L Krishnan, G E Willick, G B Patel, G D Sprott.   

Abstract

Protective immunity to intracellular bacterial pathogens usually requires the participation of specific CD8+ T cells. Natural exposure of the host to sublethal infection, or vaccination with attenuated live vaccines are the most effective means of eliciting prolonged protective cell-mediated immunity against this class of pathogens. The ability to replace these immunization strategies with defined sub-unit vaccines would represent a major advance for clinical vaccinology. The present study examines the ability of novel liposomes, termed archaeosomes, made from the polar lipids of various Archaeobacteria to act as self-adjuvanting vaccine delivery vehicles for such defined acellular antigens. Using infection of mice with Listeria monocytogenes as a model system, this study clearly demonstrates the ability of defined, archaeosome-entrapped antigens to elicit rapid and prolonged specific immunity against a prototypical intracellular pathogen. In this regard, all of the tested archaeosomes were superior to conventional liposomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348718     DOI: 10.1016/s0264-410x(01)00041-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

Review 1.  Recent advances in vaccine adjuvants.

Authors:  Manmohan Singh; Derek T O'Hagan
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

Review 2.  Archaea and their potential role in human disease.

Authors:  Paul B Eckburg; Paul W Lepp; David A Relman
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

3.  Archaeosomes display immunoadjuvant potential for a vaccine against Chagas disease.

Authors:  Leticia H Higa; Ricardo S Corral; María José Morilla; Eder L Romero; Patricia B Petray
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

4.  Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen.

Authors:  G Dennis Sprott; Subash Sad; L Perry Fleming; Chantal J Dicaire; Girishchandra B Patel; Lakshmi Krishnan
Journal:  Archaea       Date:  2003-10       Impact factor: 3.273

Review 5.  Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines.

Authors:  Bassel Akache; Felicity C Stark; Gerard Agbayani; Tyler M Renner; Michael J McCluskie
Journal:  Methods Mol Biol       Date:  2022

Review 6.  Recent advancements in cytotoxic T lymphocyte generation methods using carbohydrate-coated liposomes.

Authors:  Yuzuru Ikehara; Masahiro Yamanaka; Takashi Yamaguchi
Journal:  J Biomed Biotechnol       Date:  2010-06-17

7.  Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants.

Authors:  Bassel Akache; Felicity C Stark; Umar Iqbal; Wangxue Chen; Yimei Jia; Lakshmi Krishnan; Michael J McCluskie
Journal:  Hum Vaccin Immunother       Date:  2018-01-30       Impact factor: 3.452

8.  Liposome technology for industrial purposes.

Authors:  Andreas Wagner; Karola Vorauer-Uhl
Journal:  J Drug Deliv       Date:  2010-12-05

9.  Induction of Strong and Specific Humoral and T-helper 1 Cellular Responses by HBsAg Entrapped in the Methanobrevibacter smithii Archaeosomes.

Authors:  Mohammad Reza Aghasadeghi; Seyed Ali Delbaz; Seyed Mehdi Sadat; Seyed Davar Siadat; Mehdi Shafiee Ardestani; Pooneh Rahimi; Azam Bolhassani; Rouhollah Vahabpour Roudsari; Golnaz Bahramali; Fateme Motevalli; Mehdi Davari; Habib Vakily; Ali Sharifat Salmani; Maryam Borhan Nobari
Journal:  Avicenna J Med Biotechnol       Date:  2014-10

10.  Canadian Adjuvant Initiative Workshop, March 26-27, 2013--Ottawa, Canada.

Authors:  Lakshmi Krishnan; Susan Twine; Volker Gerdts; Luis Barreto; James C Richards
Journal:  Hum Vaccin Immunother       Date:  2013-11-05       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.